Results 11 to 20 of about 215,664 (299)
Menopause and premature ovarian insufficiency in rheumatic diseases: A review [PDF]
Гинекология, 2023 Premature ovarian insufficiency (POI) is a clinical syndrome defined as loss of ovarian function before the age of 40 years. Among the causes of POI are genetic, metabolic disorders, as well as infectious or iatrogenic factors, but in some cases the ...
Taras S. Panevin +2 more
doaj +2 more sources
Infectious diseases mimicking ovarian carcinomatosis
Gynecologic Oncology Reports, 2018 Infectious diseases can present similar to ovarian cancer and occur concomitantly with ovarian pathology. With increased worldwide travel and migration of populations, infections endemic to developing countries can emerge in the United States. We present
Sara M. Drayer, Jessica J. Shank
doaj +2 more sources
Tumor marker CA-125 in adnexal inflammatory tumors [PDF]
Vojnosanitetski Pregled, 2006 Background/Aim. The glycoprotein of a high molecular weight CA-125, which is not a specific tumor marker of ovarian cancer, is secreted by the endothelial cells of most pelvic organs. Endometriosis, inflammatory processes in the pelvic cavity, as well as
Nikolić Branka +2 more
doaj +1 more source
Performance of Ovarian Response Prediction Index As Predictor of Ovarian Response
Central Asian Journal of Medical Sciences, 2022 Objective: We aimed to evaluate potential predictors of response to controlled ovarian stimulation (COS), including follicle stimulating hormone (FSH), Estradiol, antral follicle count (AFC), and ovarian response prediction index (ORPI). Methods: In this
Bolormaa Dagvadorj +5 more
doaj +1 more source
PAX2, PAX8, and PR are correlated with ovarian seromucinous borderline tumor with endometriosis [PDF]
, 2022 Background: Ovarian "seromucinous carcinoma" has been recently removed in 2020 5th Edition of WHO classification of Female Genital Tumors and is considered as a subtype of endometrioid carcinoma with mucinous differentiation, while "seromucinous ...
신은아
core +1 more source
Ovarian Biomechanics: From Health to Disease
Frontiers in Oncology, 2022 Biomechanics is a physical phenomenon which mainly related with deformation and movement of life forms. As a mechanical signal, it participates in the growth and development of many tissues and organs, including ovary.
Chenchen Sun +4 more
doaj +1 more source
RUNX1-Regulated Signaling Pathways in Ovarian Cancer
Biomedicines, 2023 Ovarian cancer is the leading cause of gynecological death worldwide, and its poor prognosis and high mortality seriously affect the life of ovarian cancer patients.
Yuanzhi Chen, Yingying He, Shubai Liu
doaj +1 more source
Frontiers in Pharmacology, 2019 Objective: Apolipoprotein A1 (ApoA1) is remarkably decreased in serum and ovarian tissues of ovarian cancer patients. ApoA1 and ApoA1 mimetic peptides can sequestrate pro-inflammatory phospholipids, some of which are known to activate a variety of ...
Aline T. Marinho +8 more
doaj +1 more source
Human epididymis protein 4 (HE4) in benign and malignant diseases [PDF]
, 2012 Background: Human epididymis protein 4 (HE4) is described as a useful new biomarker in ovarian cancer. As HE4 is neither tumor nor organ specific, we intensively investigated the occurrence of this protein in female and male patients with various benign ...
Kirschenhofer, Angela +9 more
core +1 more source
Paraneoplastic thrombocytosis in ovarian cancer [PDF]
, 2012 <p>Background: The mechanisms of paraneoplastic thrombocytosis in ovarian cancer and the role that platelets play in abetting cancer growth are unclear.</p> <p>Methods: We analyzed clinical data on 619 patients with epithelial ...
Han, H.D. +33 more
core +1 more source